Mutations in pancreatic ß-cell Glucokinase as a cause of hyperinsulinaemic hypoglycaemia and neonatal diabetes mellitus. Review uri icon

Overview

abstract

  • Glucokinase is a key enzyme involved in regulating insulin secretion from the pancreatic ß-cell. The unique role of glucokinase in human glucose physiology is illustrated by the fact that genetic mutations in glucokinase can either cause hyperglycaemia or hypoglycaemia. Heterozygous inactivating mutations in glucokinase cause maturity-onset diabetes of the young (MODY), homozygous inactivating in glucokinase mutations result in permanent neonatal diabetes whereas heterozygous activating glucokinase mutations cause hyperinsulinaemic hypoglycaemia.

publication date

  • September 1, 2010

Research

keywords

  • Congenital Hyperinsulinism
  • Diabetes Mellitus
  • Glucokinase
  • Insulin-Secreting Cells

Identity

Scopus Document Identifier

  • 78650576114

Digital Object Identifier (DOI)

  • 10.1007/s11154-010-9147-z

PubMed ID

  • 20878480

Additional Document Info

volume

  • 11

issue

  • 3